Influenza Vaccines Market Report, Size, Share & Outlook - 2024-2031 - CSL Limited, Abbott Laboratories & Emergent BioSolutions.

The global influenza vaccines market was valued at approximately USD 6.4 billion in 2023 and is anticipated to experience substantial growth, reaching up to USD 10.8 billion by 2031. This growth is projected to occur at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031.

Influenza vaccination plays a crucial role in preventing and controlling influenza virus infections. The most common types of influenza vaccines include inactivated whole virus vaccines, split-virion vaccines, subunit vaccines, virosome influenza vaccines, live attenuated vaccines, and recombinant live viral vector vaccines. These vaccines are either commercially available or under experimental evaluation.

The growth of the influenza vaccine market is supported by increased government support and surveillance at both national and global levels, which ensures effective monitoring of vaccine supply, distribution, and administration. Additionally, rising investments from leading market players and government funding have contributed to the development and launch of more therapeutically effective vaccines, further driving market growth.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/influenza-vaccines-market

Market Trends:

Rising Number of Government Investments.

The global influenza vaccines market is driven by significant investments from governments and pharmaceutical companies. For example, the Australian government committed over $100 million to the seasonal influenza vaccine in March 2022 to protect high-risk populations. Additionally, pharmaceutical firms are channeling substantial resources into developing advanced vaccination technologies. Seqirus invested in next-generation self-amplifying mRNA technology in August 2021, aiming to improve seasonal and pandemic influenza vaccines.

Robust R&D efforts with a strong pipeline further fuel market growth. Leading companies like CSL Limited, Sanofi, and GlaxoSmithKline plc are increasing their R&D expenditures to enhance production capabilities and innovate new vaccines. Novavax's Phase 1/2 clinical study of its COVID-19-Influenza Combination Vaccine, published in April 2022, and SK Bioscience's development of a $261 million vaccine-biopharmaceutical complex in South Korea, illustrate the ongoing advancements and investments in the field.

Market Segmentation:

By Vaccine Type: Seasonal Vaccines, Pandemic Vaccines, Zoonotic Vaccines.

By Virus Type: Type A Influenza Virus, Type B Influenza Virus.

By Age Group: Children, Adult.

Get Customization Report: https://www.datamintelligence.com/customize/influenza-vaccines-market

Major Key Players:

• AstraZeneca PLC
• CSL Limited
• Abbott Laboratories
• F.Hoffmann-La Roche Ltd
• Emergent BioSolutions
• GlaxoSmithKline PLC
• Gamma Vaccines Pvt. Ltd
• Merck & Co. Inc.
• Pfizer Inc.
• Sanofi Pasteur SA

Regional Analysis:

The global Influenza Vaccines Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Influenza Vaccines Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Key Developments:

Pfizer began Phase 3 clinical trials for its mRNA-based influenza vaccine on September 14, 2022. This study aims to evaluate the effectiveness, safety, tolerability, and immunogenicity of the company's quadrivalent modified RNA (modRNA) influenza vaccine candidate, with around 25,000 healthy participants enrolled in the United States.

Related Reports:

Encephalitis Vaccines Market: https://datamintelligence.com/research-report/encephalitis-vaccines-market

Pneumococcal Vaccines Market: https://datamintelligence.com/research-report/pneumococcal-vaccines-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.